Gabapentin

Product NDC: 63629-3063
Requested package NDC: 63629-3063-8
11-digit product format: 636293063
Labeler code: 63629
Product ID: 63629-3063_f8194665-0d50-4ebd-8c82-5df9c2c8b3f2
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Gabapentin
Dosage form: TABLET
Route: ORAL
Labeler: Bryant Ranch Prepack
Application: ANDA077662
Marketing category: ANDA
Marketing start: 2006-04-01
Substance: GABAPENTIN
Active strength: 600 mg/1
Pharmacologic classes: Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A077662-001	GABAPENTIN	GABAPENTIN	600MG	TABLET / ORAL	AB1		2006-08-18
A077662-002	GABAPENTIN	GABAPENTIN	800MG	TABLET / ORAL	AB1		2006-08-18

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A077662-001	AB1
A077662-002	AB1

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A077662-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2006-08-18	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077662-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2006-08-18	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077662-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2006-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077662-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2006-08-18	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077662-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2006-08-18	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077662-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2006-08-18	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077662-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2006-08-18	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077662-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2006-08-18	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077662-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2006-08-18	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077662-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2006-08-18	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077662-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2006-08-18	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077662-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2006-08-18	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077662-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2006-08-18	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077662-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2006-08-18	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077662-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2006-08-18	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077662-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2006-08-18	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077662-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2006-08-18	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077662-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2006-08-18	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077662-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2006-08-18	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077662-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2006-08-18	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077662-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2006-08-18	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077662-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2006-08-18	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077662-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2006-08-18	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077662-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2006-08-18	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077662-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2006-08-18	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077662-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2006-08-18	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077662-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2006-08-18	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077662-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2006-08-18	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077662-001	GABAPENTIN	600MG	TABLET / ORAL	AB1	2006-08-18	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A077662-002	GABAPENTIN	800MG	TABLET / ORAL	AB1	2006-08-18	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077662-001	GABAPENTIN	600MG	TABLET / ORAL	AB	2006-08-18	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077662-002	GABAPENTIN	800MG	TABLET / ORAL	AB	2006-08-18	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077662-001	GABAPENTIN	600MG	TABLET / ORAL	AB	2006-08-18	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A077662-002	GABAPENTIN	800MG	TABLET / ORAL	AB	2006-08-18	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077662-001	GABAPENTIN	600MG	TABLET / ORAL	AB	2006-08-18	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A077662-002	GABAPENTIN	800MG	TABLET / ORAL	AB	2006-08-18	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077662-001	GABAPENTIN	600MG	TABLET / ORAL	AB	2006-08-18	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077662-002	GABAPENTIN	800MG	TABLET / ORAL	AB	2006-08-18	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077662-001	GABAPENTIN	600MG	TABLET / ORAL	AB	2006-08-18	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A077662-002	GABAPENTIN	800MG	TABLET / ORAL	AB	2006-08-18	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A077662-001	AB1	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A077662-002	AB1	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A077662-001	AB1	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A077662-002	AB1	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077662-001	AB1	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A077662-002	AB1	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A077662-001	AB1	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A077662-002	AB1	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077662-001	AB1	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A077662-002	AB1	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077662-001	AB1	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A077662-002	AB1	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077662-001	AB1	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A077662-002	AB1	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077662-001	AB1	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A077662-002	AB1	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077662-001	AB1	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A077662-002	AB1	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077662-001	AB1	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A077662-002	AB1	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A077662-001	AB1	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A077662-002	AB1	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077662-001	AB1	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A077662-002	AB1	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077662-001	AB1	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A077662-002	AB1	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077662-001	AB1	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A077662-002	AB1	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A077662-001	AB1	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A077662-002	AB1	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077662-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A077662-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A077662-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A077662-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A077662-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A077662-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A077662-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A077662-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A077662-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A077662-002	AB	1	`bb7c543d1eb4…`

Additional Listing Data#

Finished product: Yes
Brand name base: Gabapentin
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
GABAPENTIN	600 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6CW7F3G59X	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
310433	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
632cb507-5675-2392-0460-b09c0dd14650	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
cdc2ae60-922e-452d-a42f-787fe4e2ed06	Product name	1	20250123
7059096a-4b9f-36c2-db50-bb5c723e6e9e	Product name	2	20250114
fa3f0129-3502-889f-f424-3a37727959e7	Product name	9	20181206
77d89e4c-f57f-326d-d7aa-787f8eebbd2b	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
63629-3063-0	2020-02-25	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
63629-3063-1	2020-02-25	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
63629-3063-2	2020-02-25	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
63629-3063-3	2020-02-25	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
63629-3063-4	2020-02-25	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
63629-3063-5	2020-02-25	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
63629-3063-6	2020-02-25	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
63629-3063-7	2020-02-25	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
63629-3063-8	2020-02-25	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
63629-3063-9	2020-02-25	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
63629-3063-0	2020-01-31	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
63629-3063-1	2020-01-31	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
63629-3063-2	2020-01-31	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
63629-3063-3	2020-01-31	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
63629-3063-4	2020-01-31	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
63629-3063-5	2020-01-31	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
63629-3063-6	2020-01-31	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
63629-3063-7	2020-01-31	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
63629-3063-8	2020-01-31	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993
63629-3063-9	2020-01-31	These highlights do not include all the information needed to use GABAPENTIN TABLETS safely and effectively. See full prescribing information for GABAPENTIN TABLETS. GABAPENTIN tablets, for oral use Initial U.S. Approval: 1993

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
63629-3063-0	Gabapentin	45 in 1 BOTTLE	TABLET	45	19
63629-3063-1	Gabapentin	30 in 1 BOTTLE	TABLET	30	19
63629-3063-2	Gabapentin	60 in 1 BOTTLE	TABLET	60	19
63629-3063-3	Gabapentin	180 in 1 BOTTLE	TABLET	180	19
63629-3063-4	Gabapentin	90 in 1 BOTTLE	TABLET	90	19
63629-3063-5	Gabapentin	100 in 1 BOTTLE	TABLET	100	19
63629-3063-6	Gabapentin	120 in 1 BOTTLE	TABLET	120	19
63629-3063-7	Gabapentin	56 in 1 BOTTLE	TABLET	56	19
63629-3063-8	Gabapentin	84 in 1 BOTTLE	TABLET	84	19
63629-3063-9	Gabapentin	112 in 1 BOTTLE	TABLET	112	19

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63629-3063-1	EA - Each	63629-3063	2d0d8707-c28b-4f6e-9e3b-bd173fc2db46	1	2012-07-24
63629-3063-2	EA - Each	63629-3063	63161452-fd11-48fa-99dc-112354367193	1	2012-07-24
63629-3063-3	EA - Each	63629-3063	c5760a30-63f5-4844-9b79-5c4e788a6f22	1	2012-07-24
63629-3063-4	EA - Each	63629-3063	9a9b270f-6955-4176-aef0-b9ad40374acc	1	2012-07-24
63629-3063-5	EA - Each	63629-3063	93e2d1dd-625e-4c7b-876b-9b7068c9f13a	1	2012-07-24
63629-3063-6	EA - Each	63629-3063	fea6bc8f-9afe-4318-b629-18953c874fc9	1	2012-07-24
63629-3063-7	EA - Each	63629-3063	699dc091-3149-4b20-910e-b423ae5ab994	1	2015-02-02
63629-3063-8	EA - Each	63629-3063	83c1ac21-70e6-4aaa-b747-40762c001d35	1	2015-02-02
63629-3063-9	EA - Each	63629-3063	e9c81794-8880-4697-8a3a-a577fc3bc4b4	1	2015-02-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
GABAPENTIN	ACTIVE INGREDIENT	6CW7F3G59X	GABAPENTIN TABLET [BRYANT RANCH PREPACK]	3
GABAPENTIN	ACTIVE MOIETY	6CW7F3G59X	GABAPENTIN TABLET [BRYANT RANCH PREPACK]	3
COPOVIDONE K25-31	INACTIVE INGREDIENT	D9C330MD8B	GABAPENTIN TABLET [BRYANT RANCH PREPACK]	3
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	GABAPENTIN TABLET [BRYANT RANCH PREPACK]	3
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	GABAPENTIN TABLET [BRYANT RANCH PREPACK]	3
POLOXAMER 407	INACTIVE INGREDIENT	TUF2IVW3M2	GABAPENTIN TABLET [BRYANT RANCH PREPACK]	3
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	GABAPENTIN TABLET [BRYANT RANCH PREPACK]	3
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	GABAPENTIN TABLET [BRYANT RANCH PREPACK]	3
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	GABAPENTIN TABLET [BRYANT RANCH PREPACK]	3
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	GABAPENTIN TABLET [BRYANT RANCH PREPACK]	3
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	GABAPENTIN TABLET [BRYANT RANCH PREPACK]	3
WATER	INACTIVE INGREDIENT	059QF0KO0R	GABAPENTIN TABLET [BRYANT RANCH PREPACK]	3

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 10 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Gabapentin	GABAPENTIN	Coupler LLC	583ab038-7b6e-96f8-e063-6294a90adf47	2026-08-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077662 application number: ANDA077662
Gabapentin	GABAPENTIN	Unit Dose Solutions, Inc.	54edd6f3-06c7-a0c7-e063-6394a90a8b4f	2026-06-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077662 application number: ANDA077662
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	4cb26d6e-7963-4fe5-903e-ab5180545066	2026-05-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077662 application number: ANDA077662
Gabapentin	GABAPENTIN	BluePoint Laboratories	3368bf70-d466-4765-b2b7-7fe967a8c2b7	2026-04-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077662 application number: ANDA077662
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	632cb507-5675-2392-0460-b09c0dd14650	2026-04-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077662 application number: ANDA077662 ndc (package): 63629-3063-8 ndc (product): 63629-3063 ndc11 (package): 63629306308
Gabapentin	GABAPENTIN	Glenmark Pharmaceuticals Inc., USA	3865a6e3-112c-490c-82ac-35401336b16e	2025-12-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077662 application number: ANDA077662
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	137b2b9a-9d42-48d0-913f-5dc146fb689a	2025-08-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077662 application number: ANDA077662
Gabapentin	GABAPENTIN	Bryant Ranch Prepack	2278ce1b-1c19-4ad2-89c6-4530f7b78ea7	2025-07-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077662 application number: ANDA077662
Gabapentin	GABAPENTIN	PD-Rx Pharmaceuticals, Inc.	7c3b232a-3e9f-4249-9e5a-295482ee288a	2025-06-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077662 application number: ANDA077662
Gabapentin	GABAPENTIN	Proficient Rx LP	c78f528f-9192-4037-bfb9-ff5718ed26c5	2019-10-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 077662 application number: ANDA077662

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6CW7F3G59X	GABAPENTIN	60142-96-3	GABAPENTIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
310433	gabapentin 600 MG Oral Tablet	PSN	632cb507-5675-2392-0460-b09c0dd14650	19
310433	gabapentin 600 MG Oral Tablet	SCD	632cb507-5675-2392-0460-b09c0dd14650	19

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
63629-3063-8	63629306308	84 TABLET in 1 BOTTLE (63629-3063-8)	84 tablet	2026-04-07	0000-00-00	No	No	Current